相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution
Michelle Chan-Seng-Yue et al.
NATURE GENETICS (2020)
EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6
Shilpa Patil et al.
CANCER RESEARCH (2020)
Post-translational modifications of EZH2 in cancer
Zhongwei Li et al.
CELL AND BIOSCIENCE (2020)
Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progression
Marie C. Hasselluhn et al.
CELL DEATH & DISEASE (2019)
Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity
Nai-Ming Chen et al.
GASTROENTEROLOGY (2017)
Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4-and MYC-dependent manner
Vivek Kumar Mishra et al.
NUCLEIC ACIDS RESEARCH (2017)
GSK-3 inhibition overcomes chemoresistance in human breast cancer
Andrey Ugolkov et al.
CANCER LETTERS (2016)
Dissection of transcriptional and cis-regulatory control of differentiation in human pancreatic cancer
Giuseppe R. Diaferia et al.
EMBO JOURNAL (2016)
GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression
Sandra Baumgart et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers
How-Wen Ko et al.
ONCOTARGET (2016)
Heterogeneity of KRAS Mutation Status in Rectal Cancer
Peter Jo et al.
PLOS ONE (2016)
Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity
Shiv K. Singh et al.
EMBO JOURNAL (2015)
NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas
Nai-Ming Chen et al.
GASTROENTEROLOGY (2015)
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell et al.
NATURE (2015)
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
Pawel K. Mazur et al.
NATURE MEDICINE (2015)
Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells
J-S Zhang et al.
CELL DEATH & DISEASE (2014)
The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes
Robert Huether et al.
NATURE COMMUNICATIONS (2014)
Inflammation-Induced NFATc1-STAT3 Transcription Complex Promotes Pancreatic Cancer Initiation by KrasG12D
Sandra Baumgart et al.
CANCER DISCOVERY (2014)
Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
Eunhee Kim et al.
CANCER CELL (2013)
EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non-Small Cell Lung Carcinoma
Carmen Behrens et al.
CLINICAL CANCER RESEARCH (2013)
Oncogenic transcription factors: cornerstones of inflammation-linked pancreatic carcinogenesis
Sandra Baumgart et al.
GUT (2013)
被撤回的出版物: Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer (Retracted article. See vol. 238, pg. 599, 2016)
Yan-Wei Lin et al.
JOURNAL OF PATHOLOGY (2013)
NF-YA Underlies EZH2 Upregulation and Is Essential for Proliferation of Human Epithelial Ovarian Cancer Cells
Azat Garipov et al.
MOLECULAR CANCER RESEARCH (2013)
PAF and EZH2 Induce Wnt/β-Catenin Signaling Hyperactivation
Hae-Yun Jung et al.
MOLECULAR CELL (2013)
Genomic Deregulation of the E2F/Rb Pathway Leads to Activation of the Oncogene EZH2 in Small Cell Lung Cancer
Bradley P. Coe et al.
PLOS ONE (2013)
Restricted Heterochromatin Formation Links NFATc2 Repressor Activity With Growth Promotion in Pancreatic Cancer
Sandra Baumgart et al.
GASTROENTEROLOGY (2012)
EZH2 couples pancreatic regeneration to neoplastic progression
Jon Mallen-St Clair et al.
GENES & DEVELOPMENT (2012)
Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)
Michael T. McCabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
Damian B. Yap et al.
BLOOD (2011)
Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
Shuet Theng Lee et al.
MOLECULAR CELL (2011)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes
S. Fujii et al.
ONCOGENE (2011)
Myc Enforces Overexpression of EZH2 in Early Prostatic Neoplasia via Transcriptional and Post-transcriptional Mechanisms
Cheryl M. Koh et al.
ONCOTARGET (2011)
EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-β1 and is a predictor of outcome in ovarian carcinoma patients
Zhi-Yue Rao et al.
CARCINOGENESIS (2010)
NFAT-Induced Histone Acetylation Relay Switch Promotes c-Myc-Dependent Growth in Pancreatic Cancer Cells
Alexander Koeenig et al.
GASTROENTEROLOGY (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer
Paolo Kunderfranco et al.
PLOS ONE (2010)
Regulation of Pancreatic Tumor Cell Proliferation and Chemoresistance by the Histone Methyltransferase Enhancer of Zeste Homologue 2
Andrei V. Ougolkov et al.
CLINICAL CANCER RESEARCH (2008)
Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms
Raphael Margueron et al.
MOLECULAR CELL (2008)
Histone acetylation and chromatin signature in stem cell identity and cancer
Vivek Shukla et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas
Yutaka Kondo et al.
HEPATOLOGY RESEARCH (2007)
Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells
Bin Shi et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway
Malte Buchholz et al.
EMBO JOURNAL (2006)
The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer
Outi R. Saramaki et al.
GENES CHROMOSOMES & CANCER (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder
JD Raman et al.
CLINICAL CANCER RESEARCH (2005)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Amplification and overexpression of E2F3 in human bladder cancer
A Feber et al.
ONCOGENE (2004)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
The human EZH2 gene:: genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disorders
C Cardoso et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2000)
分享论文
